J. Andersson, “A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden”, AO, vol. 41, no. 3, pp. 276–281, Jan. 2002.